Urology Cancer Center, PC — Omaha, Nebraska

Urology Cancer Center, PC is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Urology Cancer Center, PC has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Prostatic Neoplasms, Metastatic Castration-Resistant Prostate Cancer, Carcinoma, Renal Cell.

Sponsors: Janssen Research & Development, LLC, POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company, AVEO Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Urology Cancer Center, PC?

Urology Cancer Center, PC has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Urology Cancer Center, PC conducted?

Urology Cancer Center, PC has 5 clinical trials on record, with 3 currently active. Their work covers Prostatic Neoplasms, Metastatic Castration-Resistant Prostate Cancer, Carcinoma, Renal Cell.

Is Urology Cancer Center, PC accredited by Crixeo Health?

Urology Cancer Center, PC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Urology Cancer Center, PC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.